Remuneration structure components

Remuneration report
CSR report

The remuneration of supervisory board members consists of (i) a fixed annual cash amount, and (ii) an equity-based component. The remuneration of the supervisory board members does not contain a variable component, and hence no performance criteria apply to their remuneration.

Remuneration structure components – Supervisory board (graphic)

In accordance with the remuneration policy and the decision of the annual shareholders’ meeting of 28 April 2020, the remuneration of the supervisory board members for the exercise of their mandate during the financial year ending 31 December 2020 consisted of the following components:

Supervisory board members

Supervisory board

Audit committee

Nomination and remuneration committee

TOTAL REMUNERATION

Cash remuneration

Equity-based remuneration

Chairman

Member

Cash (gross amount) granted to acquire GLPG shares(1)

Acquired GLPG shares(1)

Chairman

Member

Chairman

Member

Dr. Rajesh Parekh

€ 100,000

 

€ 100,000

553

 

 

€ 20,000

 

€ 220,000

Mr. Howard Rowe(2)

 

€ 50,000

€ 50,000

273

€ 20,000

 

 

€ 5,000

€ 125,000

Ms. Katrine Bosley

 

€ 50,000

€ 50,000

287

 

 

 

€ 15,000

€ 115,000

Dr. Mary Kerr

 

€ 50,000

€ 50,000

273

 

€ 15,000

 

 

€ 115,000

Mr. Peter Guenter(3)

 

€ 50,000

€ 50,000

287

 

€ 15,000

 

 

€ 115,000

Dr. Elisabeth Svanberg(4)

 

€ 33,973

€ 33,835

194

 

 

 

€ 10,192

€ 78,000

Mr. Daniel O’Day(5)

 

 

-

 

 

 

 

N/A(5)

Dr. Linda Higgins(5)

 

 

 

-

 

 

 

 

N/A(5)

(1)

The company grants a gross amount equal to the respective supervisory board member’s annual cash remuneration, to use the net amount (after taxes) to acquire shares of Galapagos in the open market

(2)

Member of the nomination and remuneration committee from 1 January 2020 until 28 April 2020

(3)

In addition to the above total remuneration, Mr. Peter Guenter received tax advisory services for €5,218.43

(4)

Member of the nomination and remuneration committee from 28 April 2020 onwards

(5)

Mr. O’Day and Dr. Higgins, both Gilead representatives, do not receive any remuneration for their mandate as supervisory board members